怀孕期间基于胆管细胞的肝脏内胆固醇症对双胞胎怀孕中围产期结局的研究
Medicine
|January 10, 2025
概括
在双胞胎怀孕中,妊娠中的肝脏内胆固醇 (ICP) 与死产和早产等不良结果有关. 诸如体重增加和乙型肝炎病毒 (HBV) 携带等因素影响ICP风险.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 周围生理学 周围生理学
背景情况:
- 妊娠中的肝脏内胆固醇症 (ICP) 是一种特定于怀孕的肝脏疾病.
- 与单子妊娠相比,双胞胎怀孕带来了独特的挑战和风险.
- 了解ICP在双胞胎怀孕中的影响,考虑到胆管性,对于优化结果至关重要.
研究的目的:
- 为了研究双胞胎怀孕中妊娠中的肝脏内胆固醇化 (ICP) 在不同胆固醇性情景中的影响.
- 为了确定与双胞胎妊娠中ICP相关的妊娠结果和风险因素.
- 用逻辑回归分析ICP,怀孕结果和风险因素之间的相关性.
主要方法:
- 追溯性研究设计.
- 后勤回归分析,以评估相关性和风险因素.
- 在双胞胎怀孕中,ICP和非ICP组之间的怀孕和新生儿结局的比较.
主要成果:
- 患有ICP的妇女经历了更少的妊娠体重增加,更少的分娩,以及更低的自发怀孕率.
- 在怀孕前携带乙型肝炎病毒 (HBV) 和使用辅助生殖技术与ICP风险有关.
- 单双胞胎的ICP与异常的羊水相关;在双双胞胎中,它增加了早产风险.
- 在双胞胎怀孕中,ICP与较高的死产率有关.
结论:
- 双胞胎怀孕中的孕产妇肝内胆固醇 (ICP) 与低出生体重和不良周产期结果有关,包括死产和早产.
- 妊娠期体重增加和妊娠前的乙型肝炎病毒 (HBV) 携带与ICP发展有显著的关联.
- ICP的风险及其相关结果在单胆双胞胎和双胆双胞胎怀孕之间有所不同.
更多相关视频
相关概念视频
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Pathophysiology of Diabetes
860
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
860
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70


